Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material

PURPOSE: The estrogen (ER), progesterone (PR), and HER2 status are essential in guiding treatment decisions in breast cancer patients. In daily life, the ER/PR/HER2 status is expected to be commonly tested twice, i.e., at diagnosis using material from tumor needle biopsies, and after tumor resection...

Descripción completa

Detalles Bibliográficos
Autores principales: Berghuis, A. M. Sofie, van Deurzen, Carolien H. M., Koffijberg, Hendrik, Terstappen, Leon W. M. M., Sleijfer, Stefan, IJzerman, Maarten J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533419/
https://www.ncbi.nlm.nih.gov/pubmed/30756285
http://dx.doi.org/10.1007/s10549-019-05141-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533419/
https://www.ncbi.nlm.nih.gov/pubmed/30756285
http://dx.doi.org/10.1007/s10549-019-05141-y

Ejemplares similares